News

Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain ...
Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...
Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...
The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...
Oscar Health (OSCR) shares rose 7% premarket on Tuesday after the company revised its full-year sales outlook.
Explore more
Oscar Mayer has become renowned for its various deli products. However, not all of them are exactly savory. Here are 8 items ...
Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook ...
Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, ...
The company announced that it now expects a loss from operations of approximately $230 million and a net loss of roughly $228 ...
In this video, I will cover Oscar Health (NYSE: OSCR) and explain why investors should not panic, despite the stock being down 40% from its recent highs. Watch the short video to learn more, consider ...
Oscar-winning actress Lupita Nyong’o opened up to fans in an Instagram post on July 15 about her painful history with uterine fibroids.